Trial Profile
Pharmacokinetics of adalimumab in patients with inflammatory bowel disease
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab
- Indications Inflammatory bowel diseases
- Focus Pharmacodynamics; Pharmacokinetics
- 12 Dec 2015 New trial record